Mihail Pautov avertizează România: Cinci milioane de români au o boală care nu doare- e vb despre ficatul gras

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in Romania is alarming, affecting an estimated 30-33% of adults. This translates to approximately 4.5-5.1 million individuals, with a significant number already experiencing progressive forms of the disease. The recent change in terminology from 'non-alcoholic fatty liver disease' to MASLD emphasizes the metabolic aspects of the condition, shifting focus from alcohol-related issues. Early detection through simple blood tests and lifestyle changes is crucial, as many individuals remain unaware of their condition until serious complications arise. The document published in the Journal of Gastrointestinal and Liver Diseases outlines a multidisciplinary approach to managing MASLD, highlighting the importance of addressing metabolic health.